Deutsche Bank’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Deutsche Bank’s Portfolio PNT Stock Details PNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-45,988	Closed	-$307K	–	3766
2023 Q3	$307K	Buy	45,988 +5,837	+15%	+$48.5K	﹤0.01%	2499
2023 Q2	$364K	Sell	40,151 -21,971	-35%	-$194K	﹤0.01%	2538
2023 Q1	$452K	Buy	62,122 +18,304	+42%	+$136K	﹤0.01%	2553
2022 Q4	$319K	Buy	43,818 +11,874	+37%	+$88.1K	﹤0.01%	2703
2022 Q3	$246K	Sell	31,944 -10,046	-24%	-$85.3K	﹤0.01%	2827
2022 Q2	$286K	Buy	+41,990	New	+$321K	﹤0.01%	2947

Other funds holding PNT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Deutsche Bank's PNT Position: Q4 2023 in Review

Deutsche Bank sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 45,988 shares — an estimated $307K sold.

Deutsche Bank first reported a position in PNT in Q2 2022 and held it in 6 quarters. The position peaked at $452K in Q1 2023. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

Deutsche Bank reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Deutsche Bank sold 45,988 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $307K.
Deutsche Bank first reported a position in POINT Biopharma Global Inc. Common Stock in Q2 2022 and held it in 6 quarters.
Deutsche Bank's POINT Biopharma Global Inc. Common Stock position peaked at $452K in Q1 2023.
1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on Deutsche Bank's 13F filing for Q4 2023, filed 14 Feb 2024.